Anti-MDA5 Positive Dermatomyositis-Associated RP-ILD
1 clinical trials · Condition
◉ Watch Anti-MDA5 Positive Dermatomyositis-Associated RP-ILD
| Record | Firm | Date |
|---|---|---|
| Nebulized MSC-Exos for Anti-MDA5+ RP-ILD: Safety and Efficacy Trial (NCT06919380) | Li Shiyue | 2025-04-15 |
Track Anti-MDA5 Positive Dermatomyositis-Associated RP-ILD automatically
Every clearance here is in the API, with alerts when new ones post.